Bone Mineral Density in Male Patients with L-Thyroxine Suppressive Therapy and Graves Disease

2001 ◽  
Vol 69 (2) ◽  
pp. 84-87 ◽  
Author(s):  
E. Jódar ◽  
G. Martínez-Díaz-Guerra ◽  
S. Azriel ◽  
F. Hawkins
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Suppressive Therapy ◽  
Graves Disease ◽  
Mineral Density ◽  
Male Patients ◽  
Thyroxine Suppressive Therapy

Bone mineral density and bone turnover markers in patients with thyroid cancer and L-T4 suppressive therapy after 25 years of follow-up

2014 ◽  
Author(s):  
Mingo Dominguez Maria Luisa de ◽  
Sonsoles Guadalix Iglesias ◽  
Maria Begona Lopez Alvarez ◽  
Guillermo Martinez Diaz-Guerra ◽  
Federico Hawkins Carranza
Keyword(s):  
Bone Mineral Density ◽  
Thyroid Cancer ◽  
Bone Turnover ◽  
Bone Mineral ◽  
Bone Turnover Markers ◽  
Suppressive Therapy ◽  
Mineral Density ◽  
Turnover Markers

Bone mineral density in male patients with type 2 diabetes mellitus, with and without hypogonadism

2017 ◽  
Author(s):  
Agathi Vasileiou ◽  
Ioanna Karathanassi ◽  
Parthena Navrozidou ◽  
Marianna Vlychou ◽  
Georgios Koukoulis ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Bone Mineral Density ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Bone Mineral ◽  
Mineral Density ◽  
Male Patients

scholarly journals Prevalence of Osteoporosis in Male Patients with Chronic Obstructive Pulmonary Disease

2018 ◽  
Vol 30 (1) ◽  
pp. 1-4
Author(s):  
Mohammad Zabed Jillul Bari ◽  
Md Ismail Patwary ◽  
Md Delwar Hossain ◽  
Azizul Qadar Md Abdul Hye ◽  
Syed Mujibur Rahman
Keyword(s):  
Bone Mineral Density ◽  
Lumbar Spine ◽  
Femoral Neck ◽  
Bone Mineral ◽  
Oral Steroid ◽  
Mineral Density ◽  
Normal Bone ◽  
Normal Bone Mineral Density ◽  
Male Patients ◽  
Prevalence Of Osteoporosis

Osteoporosis is one of the systemic features of COPD. Aims and objective is to determine the prevalence of osteoporosis in male COPD. In a cross-sectional study, we conducted dual-energy X-ray absorptiometry bone mineral density scans of the femoral neck and lumbar spine and collected data on smoking, duration of COPD, inhaled and oral corticosteroid treatment and staging by pulmonary function tests. We included 60 male patients with COPD, the mean age was 62.4 ± 8.1 years, smoking was 36.8 ± 17.2 smoking-pack year, duration of COPD was 5.4 ± 3.3 years, GOLD stage-III (56.7%) stage-IV (38.3%) and stage-II (5.0%), use of oral steroid (11.7%) inhaled steroid (63.3%) and none (25.0%). Normal bone mineral density was in 6 (10.0%), osteopenia in 24 (40.0%) and osteoporosis in 30 (50%) patients in femoral neck; whereas normal bone mineral density was in 4 (6.7%), osteopenia in 17 (28.3%) and osteoporosis in 39 (65.0%) patients in lumbar spine. Osteoporosis is highly prevalent in male COPD patients in both femoral neck and lumbar spine.Medicine Today 2018 Vol.30(1): 1-4

Sign in / Sign up

Export Citation Format

Share Document